Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Managed Access Program Supporting Patient Access to Tebentafusp (Non Applicable)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04960891
Expanded Access Status : Available
First Posted : July 14, 2021
Last Update Posted : July 14, 2021
Sponsor:
Collaborator:
Clinigen, Inc.
Information provided by (Responsible Party):
Immunocore Ltd

Brief Summary:
A managed access program to support patient access to Tebentafusp outside of clinical trials or to where Tebentafusp is not yet available.

Condition or disease Intervention/treatment
Uveal Melanoma Biological: Tebentafusp

Layout table for study information
Study Type : Expanded Access
  See clinical trials of the intervention/treatment in this expanded access record.
Official Title: A Managed Access Program Which Will Support Patient Access to Tebentafusp Outside of Clinical Trials or Where Tebentafusp is Not Yet Available



Intervention Details:
  • Biological: Tebentafusp
    Concentrate solution for intravenous infusion
    Other Name: non applicable

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Criteria

Inclusion Criteria:

  • To be disclosed on a per patient basis

Exclusion Criteria:

  • To be disclosed on a per patient basis

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04960891


Contacts
Layout table for location contacts
Contact: Medical Information 00441235438600 medical.information@immunocore.com

Sponsors and Collaborators
Immunocore Ltd
Clinigen, Inc.
Layout table for additonal information
Responsible Party: Immunocore Ltd
ClinicalTrials.gov Identifier: NCT04960891    
Other Study ID Numbers: Non Applicable
First Posted: July 14, 2021    Key Record Dates
Last Update Posted: July 14, 2021
Last Verified: July 2021